Although contrast-enhanced computed tomography (CT), dynamic magnetic resonance (MRI) and fine needle biopsy (FNB) are the standard of care to diagnose hepatocellular carcinoma (HCC), the clinical and economic benefits of the updated AASLD diagnostic algorithm, including the drop of contrast enhanced ultrasound (CEUS), have not been previously evaluated.

Manini, M., Sangiovanni, A., Fornari, F., Piscaglia, F., Biolato, M., Fanigliulo, L., Ravaldi, E., Grieco, A., Colombo, M., Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma, <<JOURNAL OF HEPATOLOGY>>, 2014; 60 (5): 995-1001. [doi:10.1016/j.jhep.2014.01.006] [http://hdl.handle.net/10807/61669]

Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma

Grieco, Antonio;
2014

Abstract

Although contrast-enhanced computed tomography (CT), dynamic magnetic resonance (MRI) and fine needle biopsy (FNB) are the standard of care to diagnose hepatocellular carcinoma (HCC), the clinical and economic benefits of the updated AASLD diagnostic algorithm, including the drop of contrast enhanced ultrasound (CEUS), have not been previously evaluated.
2014
Inglese
Manini, M., Sangiovanni, A., Fornari, F., Piscaglia, F., Biolato, M., Fanigliulo, L., Ravaldi, E., Grieco, A., Colombo, M., Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma, <<JOURNAL OF HEPATOLOGY>>, 2014; 60 (5): 995-1001. [doi:10.1016/j.jhep.2014.01.006] [http://hdl.handle.net/10807/61669]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/61669
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 59
  • ???jsp.display-item.citation.isi??? 50
social impact